North America Scar Treatment Market Estimated To Witness High...

North America Scar Treatment Market Estimated To Witness High Growth Owing To Increasing Demand For Minimally Invasive Procedures

Postado 2023-12-21 09:51:41

The North America scar treatment market offers a wide range of products for scar treatment through minimally invasive procedures. Laser therapy, fractionated laser resurfacing, microdermabrasion and chemical peels are some of the popular non-invasive scar removal procedures used in the region. These procedures effectively reduce the appearance of scars by removing the top layer of damaged skin and stimulating the formation of new, healthy skin.

The global North America scar treatment market is estimated to be valued at US$ 4,348.7 million in 2023 and is expected to exhibit a CAGR of 4.3% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:

One of the major drivers fueling the growth of the North America scar treatment market is the increasing demand for minimally invasive scar removal procedures. These procedures such as laser therapy offer advantages like minimal pain, fewer complications, reduced recovery time and ability to treat all types of scars effectively. They provide scar reduction in a more convenient way than surgery with long term benefits. Moreover, the growth is also supported by rising aesthetic consciousness among consumers and increasing FDA clearances for innovative scar treatment products. However, high costs of scar removal treatments and limitations of certain procedures to treat severe scars may hinder the market growth.

SWOT Analysis

Strength: The North America scar treatment market has strong presence of key players with established supply chains and wide distribution networks. These players invest heavily in R&D to develop advanced scar treatment products. They offer a variety of scar treatment options such as scar creams, gels, sheets, injections and laser treatment. This wide range of scar treatment options caters to different scar types and needs of consumers.

Weakness: Scar treatment products require regular application over long periods of time to reduce appearance of scars completely. This makes scar treatment a lengthy process. Additionally, high costs of certain advanced scar treatment methods like laser treatment limit their adoption.

Opportunity: Growing awareness about scar treatment options and rising preference for minimizing appearance of scars through non-invasive methods present lucrative opportunities. There is high scope for developing cost-effective scar treatment products. Increasing obese population prone to surgical scars will boost demand.

Threats: Easy availability of generic scar treatment products poses threat from local and unorganized players. Presence of alternative skin therapies and issues regarding efficacy and safety of certain new products are other threats.

Key Takeaways

The Global North America Scar Treatment Market Size is expected to witness high growth over the forecast period. Factors such as rising disposable incomes, growing obese population undergoing various surgeries and increasing awareness about scar treatment options will fuel market expansion. The global North America scar treatment market is estimated to be valued at US$ 4,348.7 Mn in 2023 and is expected to exhibit a CAGR of 4.3% over the forecast period 2023 to 2030.

Regional analysis: North America dominates the global scar treatment market with the largest share currently. The US accounts for the major share within the region owing to presence of many key players, higher healthcare spending and growing obese population undergoing various surgeries. The scar treatment market in the US is projected to grow at a CAGR of 4.2% during the forecast period.

Key players: Key players operating in the North America scar treatment market are ScarAway, Thrive Aesthetics MN, HRA Pharma, MARLO WHITNEY, Smith & Nephew Inc, Merz Therapeutics, Enaltus LLC, Oculus Innovative Sciences, Inc, CCA Industries, Bausch Health Companies Inc., Candela Medical, Perrigo Company plc, Sonoma Pharmaceuticals, Inc., Hologic, Inc., Johnson & Johnson Surface Treatment, Inc., Quantum Health, AVITA Medical, Revitol Corp, Scarguard labs, Lumenis Be Ltd, Cynosure, GC Aesthetics, Sientra, Inc, SkinCeuticals, Cimeosil.com, Honeydew Products, 3V Sigma USA Inc., Syneron Medical Ltd.